OVALITH-300 Implantable Pacemaker Pulse-Generator
510(k) K790446
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK790446 | Date30 Jul 1979 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Full name
- Ovalith-300
- 510(k) Number
- FDA Product Code
- DXY
- Device Class
- Class III
- Regulation
- 21 CFR Part 870.3610
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 18 Sep 2026
The Ovalith-300 is an Implantable Pacemaker Pulse-Generator, a Class III medical device designed to regulate heart rhythm by delivering electrical impulses to the heart muscle when spontaneous contractions are insufficient. It is intended for patients with bradycardia or other conduction disorders requiring chronic cardiac pacing.
This device is supplied as a reusable, implantable component and is regulated under FDA 510(k) clearance (K790446) as a substantially equivalent device to prior generations. It is classified under regulation number 870.3610 and falls under the Cardiovascular specialty category, adhering to strict manufacturing and sterility standards for implantable electronics. No additional context on MRI safety, single-use status, or specific storage requirements is provided in the available data.
Other devices from Coratomic, Inc.
Questions
AI-generated answers, 18 Sep 2026
Is the Ovalith-300 designed for single-use or can it be reused after implantation?
The Ovalith-300 is explicitly described as a reusable, implantable component. Since it is intended for long-term cardiac pacing and classified under FDA regulation 870.3610 for implantable electronics, it is not a single-use device. Reuse is permitted as part of its design and regulatory pathway, though proper sterilization and handling protocols must be followed per manufacturer guidelines.
What types of heart conditions is the Ovalith-300 approved to treat, and how does it work?
The Ovalith-300 is intended for patients with bradycardia or conduction disorders requiring chronic cardiac pacing. It works by delivering electrical impulses to the heart muscle when the heart’s natural contractions are insufficient, thereby regulating heart rhythm. This is a standard function of implantable pacemaker pulse-generators, and the device’s approval reflects its role in managing these specific cardiac conditions.
How is the Ovalith-300 regulated by the FDA, and what does its classification mean for clinicians?
The Ovalith-300 is a Class III medical device regulated under FDA 510(k) clearance (K790446) and falls under regulation number 870.3610. This classification means it is subject to strict manufacturing and sterility standards, as it is an implantable electronic device. The device was deemed substantially equivalent to prior generations, ensuring it meets existing safety and performance criteria for pacemaker pulse-generators.
Does the Ovalith-300 come with any specific storage requirements, and is it sterile upon receipt?
The provided data does not explicitly detail storage requirements or sterility status for the Ovalith-300. However, as an implantable device regulated under FDA standards for electronics, it must adhere to strict manufacturing protocols to ensure sterility before use. Clinicians should follow the manufacturer’s instructions for handling, storage, and preparation to maintain device integrity and patient safety.